Deep Vein Thrombosis
📧 Sign up to get email alerts when something new happens for Deep Vein Thrombosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-09-15FDA Approved: SAVAYSA — Supplemental Application (Daiichi Sankyo Inc.)
The FDA approved a supplemental application for SAVAYSA (edoxaban tosylate) from Daiichi Sankyo Inc., expanding the drug's regulatory status…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
A completed clinical trial evaluating the exclusion of venous thromboembolism using the STA-Liatest D-Di assay. The study involves deep vein…
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Optimal Duration of Anticoagulation in Deep Venous Thrombosis [Phase 3]
Phase 3 trial evaluating the optimal duration of anticoagulation for deep vein thrombosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin [Phase 4]
This Phase 4 trial compared three-times-daily unfractionated heparin to twice-daily enoxaparin for venous thromboembolism prophylaxis after …
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids [Phase 1]
Phase 1 pediatric trial evaluating the use of bivalirudin for clots in children with deep vein thrombosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients [Phase 3]
This document reports Phase 3 results evaluating the safety and efficacy of apixaban in Japanese patients with acute deep vein thrombosis or…
-
CLINICAL_TRIALS withdrawal · 2016-06-22Clinical Trial Update: Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients
A multicenter registry study evaluating comparative effectiveness of venous thromboembolism management in trauma patients has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: General Practitioner-performed Compression Ultrasound for Deep Vein Thrombosis
A completed trial assessing whether general practitioners can perform compression ultrasound to diagnose deep vein thrombosis.
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Predictors of Anticoagulation Control on Warfarin Therapy
A completed clinical trial update examining predictors of maintaining therapeutic anticoagulation with warfarin in patients with atrial fibr…
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Genotype-Guided Warfarin Therapy Trial [NA]
This document provides an update on a completed clinical trial evaluating genotype-guided dosing of warfarin across patients with atrial fib…
-
CLINICAL_TRIALS research · 2016-04-27Clinical Trial Update: Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion
This document provides an update on a clinical study that examines how often early deep vein thrombosis occurs after peripherally inserted c…
-
FDA approval · 2016-04-25FDA Approved: SAVAYSA — Supplemental Application (Daiichi Sankyo Inc.)
The FDA approved a supplemental application for SAVAYSA (edoxaban tosylate) submitted by Daiichi Sankyo to modify the label, reflecting upda…
-
CLINICAL_TRIALS withdrawal · 2016-04-22Clinical Trial Update: Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
This study evaluating the Crux Vena Cava Filter System was withdrawn; no study results have been reported.
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs [Phase 3]
A Phase 3 bioequipotency study comparing Idrabiotaparinux and Idraparinux in patients with Deep vein thrombosis of the lower limbs has compl…
-
FDA approval · 2016-02-18FDA Approved: FONDAPARINUX SODIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for fondaparinux sodium from Dr. Reddy's Laboratories Limited, enabling a new generic version of the…
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT [Phase 3]
A Phase 3 trial comparing bemiparin to enoxaparin for the treatment of deep vein thrombosis has completed, with an efficacy update provided …
-
CLINICAL_TRIALS research · 2016-01-08Clinical Trial Update: Ongoing Registry of Deep Venous Reconstructions
This document reports an ongoing registry trial evaluating deep venous reconstructions for venous thrombosis, currently recruiting at Maastr…
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery [Phase 3]
This document reports the completion and results posting of a Phase 3 trial evaluating apixaban for prevention of thrombosis-related events …
-
CLINICAL_TRIALS trial_result · 2015-11-23Clinical Trial Update: Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis [Phase 1]
This Phase 1 clinical trial reports results comparing anti-XA levels in women after cesarean delivery who received enoxaparin thromboprophyl…
-
CLINICAL_TRIALS research · 2015-11-18Clinical Trial Update: Understanding Risk Factors Involved in Developing a Second Blood Clot.
This document reports an update on a clinical trial investigating risk factors for developing a second blood clot in patients with deep vein…
-
FDA approval · 2015-11-13FDA Approved: HEPARIN SODIUM — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Heparin Sodium submitted by Fresenius Kabi USA, LLC (NDA 017651). The approval updates labeling …
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin [Phase 4]
Phase 4 clinical trial update evaluating the occurrence of asymptomatic deep vein thrombosis in patients undergoing orthopedic replacement s…
-
FDA approval · 2015-10-26FDA Approved: XARELTO — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for XARELTO (rivaroxaban) submitted by Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery
A completed clinical trial assessing dabigatran etexilate 150 mg once daily for prevention of thromboembolism after hip or knee replacement …
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: The Clinical Application of Infrared Thermal Imaging Detecting Venous Thromboembolism
The study evaluated infrared thermal imaging as a diagnostic method for detecting venous thromboembolism in patients with deep vein thrombos…